Rep. Gilbert Ray Cisneros Jr. (D-CA) Sells Revvity (RVTY) Stock
Democratic Rep. Gilbert Ray Cisneros Jr. sold shares of Revvity valued between $15,001 and $50,000.
Reviewed by automated data checks against the source filing. How we make and check alerts
Rep. Gilbert Ray Cisneros Jr. (D-CA) sold between $15,001 and $50,000 of Revvity, Inc. ($RVTY) stock on September 9, 2026. The trade was disclosed in a STOCK Act periodic transaction report filed October 12, 2026.
Since the trade, $RVTY is up 17.7% after 1 week, up 24.5% after 1 month and up 23.2% to date (from the $123.85 close on Sep 9, 2026).
Financial Disclosure Report
Clerk of the House of Representatives • Legislative Resource Center • B81 Cannon Building • Washington, DC 20515
Filer Information
- Name:
- Rep. Gilbert Ray Cisneros Jr. (D)
- Status:
- Member — House
- Party:
- Democrat
Filing Information
- Filing Type:
- Periodic Transaction Report
- Filing Year:
- 2026
- Filing Date:
- Oct 12, 2026
Schedule B: Transactions
| Asset | Transaction | Date | Amount |
|---|---|---|---|
| Revvity, Inc. ($RVTY) | Sell | Sep 9, 2026 | $15,001 - $50,000 |
Summary of the filed report, not the original document. View the original: STOCK Act disclosure (House Clerk)
RVTY
Revvity, Inc.
Key Points
- Democratic Rep. Gilbert Ray Cisneros Jr. sold Revvity shares worth between $15,001 and $50,000, as disclosed on October 12, 2026.
- Revvity, Inc. trades on the NYSE under RVTY, with shares priced around $153.35 on Friday and a market cap of $16.02 billion.
- Revvity has a P/E ratio of 69.03 and a forward P/E of 24.37, with a 52-week high of $149.52 and a low of $81.22.
Get $RVTY trade alerts by text
We text you when insiders, Congress or big funds trade $RVTY. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Revvity, Inc. alert may contain errors. Disclosures
Democratic Representative Gilbert Ray Cisneros Jr. from California's 31st district recently sold shares of Revvity, Inc. The transaction, reported on October 12, 2026, revealed that the shares were valued between $15,001 and $50,000. This sale adds to the list of stock trades disclosed by members of Congress as part of the STOCK Act.
Gilbert Ray Cisneros Jr. vs. the S&P 500
Hypothetical returns from Gilbert Ray Cisneros Jr.'s disclosed trades, not real profit or advice. How we model this.
Revvity, Inc. Stock Up 6.9%
Shares of Revvity, Inc. (NYSE:RVTY) were trading near $153.35 on Friday. The company has a market capitalization of approximately $16.02 billion. Revvity has a price-to-earnings ratio of 69.03 and a forward P/E of 24.37, indicating investor expectations for future earnings growth. The stock's beta is 1.089, suggesting moderate volatility. Over the past year, Revvity's stock has ranged from a low of $81.22 to a high of $149.52. Its 50-day moving average is $120.85, while the 200-day moving average stands at $104.10.
Recent Earnings
Revvity reported revenue of about $2.91 billion with a slight growth rate of 1.3%. The company's earnings per share (EPS) is 2.08, and it maintains a net margin of 8.16%. Return on equity (ROE) is relatively low at 3.21%. Investors should watch for the next earnings report scheduled for October 26, 2026.
Dividend
Revvity pays an annual dividend rate of $0.28, yielding around 0.2%. The dividend payout ratio is a conservative 13.46%, indicating that the company retains a significant portion of its earnings for reinvestment or other purposes.
About Revvity, Inc.
Revvity, Inc., headquartered in Waltham, Massachusetts, operates in the healthcare sector, specifically within the diagnostics and research industry. The company offers a range of health science solutions, including instruments, reagents, and software for diagnostics and research. Revvity serves various clients, including pharmaceutical companies, research institutions, and healthcare organizations. Led by CEO Dr. Prahlad R. Singh, Revvity employs about 11,000 people and continues to innovate in genomic workflows and diagnostic testing.
Bottom Line
Rep. Gilbert Ray Cisneros Jr.'s sale of Revvity shares highlights the ongoing financial activity of U.S. lawmakers. Investors often track these trades for potential insights, though they reflect past actions and may not indicate current holdings. Revvity remains a notable player in the healthcare diagnostics field, with a strong market presence and upcoming earnings report that could influence investor sentiment.
Related Filing Alerts
Source: Gilbert Ray Cisneros Jr.'s STOCK Act disclosure on $RVTY (Sep 9, 2026). Read the original filing: STOCK Act disclosure (House Clerk). Written by software, not financial advice. How we make alerts